Live Breaking News & Updates on Bmo Capital Markets|Page 20
Stay updated with breaking news from Bmo capital markets. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Bristol-Myers Squibb (NYSE:BMY – Get Free Report) had its target price dropped by stock analysts at BMO Capital Markets from $55.00 to $48.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has a “market perform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price objective would […] ....
CoStar Group (NASDAQ:CSGP – Free Report) had its price objective increased by BMO Capital Markets from $84.00 to $88.00 in a research report report published on Thursday morning, Benzinga reports. The firm currently has a market perform rating on the technology company’s stock. Several other analysts have also recently issued reports on the stock. Needham […] ....
Silvercorp Metals (TSE:SVM – Free Report) had its target price increased by BMO Capital Markets from C$5.00 to C$6.00 in a research note released on Thursday morning, BayStreet.CA reports. SVM has been the subject of a number of other research reports. Canaccord Genuity Group lowered their target price on Silvercorp Metals from C$7.50 to C$7.00 […] ....
International Business Machines (NYSE:IBM – Free Report) had its target price cut by BMO Capital Markets from $210.00 to $190.00 in a research note published on Thursday morning, Benzinga reports. They currently have a market perform rating on the technology company’s stock. Several other equities research analysts also recently weighed in on the company. Sanford […] ....